Greenwich Lifesciences Inc
NASDAQ:GLSI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Greenwich Lifesciences Inc
NASDAQ:GLSI
|
US |
|
A
|
Apollo Sindoori Hotels Ltd
NSE:APOLSINHOT
|
IN |
|
Kelsian Group Ltd
ASX:KLS
|
AU |
|
Teck Resources Ltd
NYSE:TECK
|
CA |
|
Genmin Ltd
ASX:GEN
|
AU |
|
Northwest Natural Holding Co
NYSE:NWN
|
US |
|
OptiBiotix Health PLC
LSE:OPTI
|
UK |
|
O
|
OpenSys (M) Bhd
KLSE:OPENSYS
|
MY |
|
A
|
Atlan Holdings Bhd
KLSE:ATLAN
|
MY |
|
Agilysys Inc
NASDAQ:AGYS
|
US |
|
HG Infra Engineering Ltd
BSE:541019
|
IN |
|
Mav Beauty Brands Inc
TSX:MAV
|
CA |
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
|
H
|
HansaeMK Co Ltd
KRX:069640
|
KR |
|
Bank Victoria International Tbk PT
IDX:BVIC
|
ID |
|
A
|
Anglo American Platinum Ltd
JSE:AMS
|
ZA |
|
V
|
Vinafreight JSC
VN:VNF
|
VN |
|
Solytech Enterprise Corp
TWSE:1471
|
TW |
|
K
|
Klaipedos Nafta AB
F:XIC
|
LT |
|
Golden Agri-Resources Ltd
SGX:E5H
|
SG |
|
YOUZU Interactive Co Ltd
SZSE:002174
|
CN |
|
Ozon Holdings PLC
MOEX:OZON
|
CY |
|
Yesco Holdings Co Ltd
KRX:015360
|
KR |
|
G
|
Grodno SA
WSE:GRN
|
PL |
Cash Flow Statement
Cash Flow Statement
Greenwich Lifesciences Inc
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||
| Net Income |
(4)
|
(5)
|
(3)
|
(4)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(5)
|
(6)
|
(6)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(16)
|
(17)
|
(18)
|
(19)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
7
|
7
|
9
|
10
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
7
|
8
|
9
|
10
|
|
| Change in Working Capital |
4
|
5
|
3
|
3
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
+32%
|
(0)
-123%
|
(0)
+28%
|
(0)
N/A
|
(0)
N/A
|
(1)
-448%
|
(2)
-46%
|
(2)
-36%
|
(3)
-39%
|
(4)
-35%
|
(6)
-33%
|
(6)
+1%
|
(6)
-12%
|
(6)
+1%
|
(6)
+6%
|
(6)
-7%
|
(6)
-4%
|
(6)
+0%
|
(7)
-3%
|
(7)
-1%
|
(8)
-12%
|
(7)
+4%
|
(7)
-1%
|
(9)
-16%
|
(9)
-1%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
6
|
30
|
33
|
33
|
27
|
3
|
(5)
|
(7)
|
(7)
|
(8)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
5
|
4
|
6
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
6
N/A
|
30
+364%
|
32
+8%
|
32
N/A
|
26
-19%
|
3
-89%
|
(5)
N/A
|
(7)
-41%
|
(7)
N/A
|
(8)
-8%
|
(2)
+73%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
+925%
|
4
+39%
|
4
+3%
|
5
+4%
|
4
-3%
|
7
+49%
|
|
| Change in Cash | |||||||||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
(0)
N/A
|
(0)
+38%
|
0
N/A
|
0
N/A
|
6
N/A
|
29
+361%
|
30
+6%
|
30
-2%
|
23
-24%
|
(1)
N/A
|
(11)
-630%
|
(13)
-18%
|
(13)
-5%
|
(14)
-3%
|
(8)
+43%
|
(6)
+20%
|
(6)
-4%
|
(6)
+0%
|
(6)
+1%
|
(4)
+42%
|
(3)
+11%
|
(3)
+13%
|
(3)
+5%
|
(4)
-49%
|
(2)
+51%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
+32%
|
(0)
-123%
|
(0)
+28%
|
(0)
N/A
|
(0)
N/A
|
(1)
-448%
|
(2)
-46%
|
(2)
-36%
|
(3)
-39%
|
(4)
-35%
|
(6)
-33%
|
(6)
+1%
|
(6)
-12%
|
(6)
+1%
|
(6)
+6%
|
(6)
-7%
|
(6)
-4%
|
(6)
+0%
|
(7)
-3%
|
(7)
-1%
|
(8)
-12%
|
(7)
+4%
|
(7)
-1%
|
(9)
-16%
|
(9)
-1%
|
|